“MedApp S.A. has achieved very good financial results. We obtained revenues of PLN 1,944,000 and a net result of PLN 376,000. This is another very good quarter in which the Company achieves positive financial results. These figures are the effect of passion and determination of MedApp Team, but also of the use of unique, innovative technological solutions based on software dedicated to medical services,” comments Krzysztof Mędrala, CEO of MedApp S.A. on the operational and financial results of Q1 2021.
Watch the video!
If you have investor questions and would like to know more, please contact us at email@example.com
Read more See similar articles:
CarnaLife System will enable remote monitoring of patients of the TeleMed24 Operations and Support Center
With the cooperation established between MedApp S.A. and MKW S.A., the owner of the TeleMed24 brand, patients under the care of the Bytom facility will gain access to full, remote monitoring and diagnostics of heart and circulatory system diseases based on the CarnaLife System platform solutions.
MedApp continues global expansion and launches operations in the Brazilian market
The signed agreement covers the sale of the CarnaLife Holo technology. In the coming week, training sessions for our distributor’s representatives in Brazil are starting. We expect that before the end of the year, the first demonstration treatments using CarnaLife Holo in Brazilian hospitals will be possible.
MedApp S.A., is the partner of the nationwide contest for schoolgirls “Become an Ambassador”.
On October 11, 2021, in celebration of the International Day of the Girl, 12 finalists of the nationwide contest for schoolgirls “Become an Ambassador” were given the opportunity to learn about the world of diplomacy by playing the role of an Ambassador in one of the participating Embassies.